Sign inGet started

Fratamico Arthur

Insider CIK 1598129 · SNBP Director · VTAE Chief Business Officer · GRTX Chief Business Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PBLA Panbela Therapeutics, Inc. A Award deriv2023-03-272023-03-298,333— $08,333SEC↗
PBLA Panbela Therapeutics, Inc. A Award deriv2021-05-252021-05-2712,368— $012,368SEC↗
PBLA Panbela Therapeutics, Inc. A Award2021-05-252021-05-274,316— $09,615SEC↗
GRTX Galera Therapeutics, Inc. A Award deriv2021-01-262021-01-2875,000— $075,000SEC↗
PBLA Panbela Therapeutics, Inc. A Award2020-12-012020-12-032,875— $05,299SEC↗
SNBP Sun BioPharma, Inc. P Buy deriv2020-09-012020-09-012,424— $02,424SEC↗
SNBP Sun BioPharma, Inc. P Buy2020-09-012020-09-012,424— $02,424SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2020-06-242020-06-2612,000— $012,000SEC↗
GRTX Galera Therapeutics, Inc. A Award deriv2020-01-312020-02-0474,435— $074,435SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2019-12-192019-12-2326,800— $026,800SEC↗
SNBP Sun BioPharma, Inc. A Award deriv2019-12-192019-12-236,500— $06,500SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-25152,173$15.71 $2.39M0SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-2513,750$12.72 $174.9K0SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-2519,250$12.42 $239.1K0SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-2514,500$12.22 $177.2K0SEC↗
VTAE Vitae Pharmaceuticals, Inc D To issuer deriv2016-10-252016-10-2513,750$6.60 $90.8K0SEC↗
VTAE Vitae Pharmaceuticals, Inc U Tender2016-10-242016-10-2513,233$21.00 $277.9K0SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2016-08-152016-08-1714,500— $014,500SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award2016-04-292016-08-172,086$6.11 $12.7K12,086SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2016-02-152016-02-1619,250— $019,250SEC↗
VTAE Vitae Pharmaceuticals, Inc P Buy2015-08-272015-08-3110,000$7.83 $78.3K10,000SEC↗
VTAE Vitae Pharmaceuticals, Inc A Award deriv2015-02-132015-02-1813,750— $013,750SEC↗